Objective To profile RNA expression in gastric cancer by anatomic subsites as an initial step in identifying molecular subtypes and providing targets for early detection and therapy. Methods We performed transcriptome analysis using the Affymetrix GeneChip U133A in gastric cardia adenocarcinomas (n = 62) and gastric noncardia adenocarcinomas (n = 72) and their matched normal tissues from patients in Shanxi Province, and validated selected dysregulated genes with additional RNA studies. Expression of dysregulated genes was also related to survival of cases. Results Principal Component Analysis showed that samples clustered by tumor vs. normal, anatomic location, and histopathologic features. Paired t-tests of tumor/normal tissues identified 511 genes whose expression was dysregulated (P<4.7E-07 and at least two-fold difference in magnitude) in cardia or noncardia gastric cancers, including nearly one-half (n = 239, 47%) dysregulated in both cardia and noncardia, one-fourth dysregulated in cardia only (n = 128, 25%), and about one-fourth in noncardia only (n = 144, 28%). Additional RNA studies confirmed profiling results. Expression was associated with case survival for 20 genes in cardia and 36 genes in noncardia gastric cancers. Conclusions The dysregulated genes identified here represent a comprehensive starting point for future efforts to understand etiologic heterogeneity, develop diagnostic biomarkers for early detection, and test molecularly-targeted therapies for gastric cancer.
References
[1]
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108.
[2]
Li JY (1982) Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 62: 113–120.
[3]
Sun X, Mu R, Zhou Y, Dai X, Qiao Y, et al. (2002) [1990–1992 mortality of stomach cancer in China]. Zhonghua Zhong Liu Za Zhi 24: 4–8.
[4]
Cancer Institute CAoMS (2011) China Cancer Database. http://cancernet.cicams.ac.cn. (accessed 2013 Apr 14)
[5]
Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, et al. (2010) Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303: 1723–1728 303/17/1723 [pii];10.1001/jama.2010.496 [doi].
[6]
Gao Y, Hu N, Han XY, Ding T, Giffen C, et al. (2011) Risk factors for esophagel and gastric cancers in Shanxi Province, China: A case-control study. Cancer Epidemiol 35: e91–e99.
[7]
Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, et al. (1993) Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85: 1492–1498.
[8]
Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, et al. (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92: 1753–1763.
[9]
Wei W, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, et al. (2004) Prospective study of serum selenium concentration and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79: 80–85.
[10]
Gao Y, Hu N, Han X, Giffen C, Ding T, et al. (2009) Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 9: 269.
[11]
Sipponen P (1995) Helicobacter pylori: a cohort phenomenon. Am J Surg Pathol 19 Suppl 1S30–S36.
[12]
Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, et al. (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113: 456–463.
[13]
Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, et al. (2007) Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96: 172–176.
[14]
Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, et al. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85: 1483–1492.
[15]
Qiao YL, Dawsey SM, Kamangar F, Abnet CC, Johnson LL, et al. (2009) Total and cancer mortality following supplementation with vitamins and minerals: Post-intervention follow-up of the General Population Nutrition Intervention Trial in Linxian China. J Natl Cancer Inst 101: 507–518.
[16]
Lauren P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at histo-clinical classification. Acta Pathol Microbiol Scand 64: 31–49.
[17]
Liu SF, Shen Q, Dawsey SM, Wang GQ, Nieberg RK, et al. (1994) Esophageal balloon cytology and subsequent risk of esophageal and gastric-cardia cancer in a high-risk Chinese population. Int J Cancer 57: 775–780.
[18]
Corley DA, Kubo A (2004) Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 96: 1383–1387 10.1093/jnci/djh265 [doi];96/18/1383 [pii].
[19]
Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, et al. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 42: 764–767 ng.649 [pii];10.1038/ng.649 [doi].
[20]
Gleeson CM, Sloan JM, McManus DT, Maxwell P, Arthur K, et al. (1998) Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer 77: 277–286.
[21]
Berx G, Becker KF, Hofler H, van RF (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12: : 226–237. 10.1002/(SICI)1098-1004(1998)12:4<226::A？ID-HUMU2>3.0.CO;2-D[pii];10.1002/(SICI)1098-1004(1998)12:4<？226::AID-HUMU2>3.0.CO;2-D[doi].
[22]
Park WS, Oh RR, Park JY, Lee SH, Shin MS, et al. (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59: 4257–4260.
[23]
Park WS, Oh RR, Park JY, Lee JH, Shin MS, et al.. (2000) Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119: 691–698. S0016508500762664 [pii].
[24]
Lee JH, Han SU, Cho H, Jennings B, Gerrard B, et al. (2000) A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 19: 4947–4953 10.1038/sj.onc.1203874 [doi].
[25]
Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, et al. (2002) Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62: 7012–7017.
[26]
Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, et al. (2004) Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 23: 6830–6844 10.1038/sj.onc.1207886 [doi];1207886 [pii].
[27]
Boussioutas A, Li H, Liu J, Waring P, Lade S, et al. (2003) Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 63: 2569–2577.
[28]
Weiss MM, Kuipers EJ, Postma C, Snijders AM, Siccama I, et al. (2003) Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 22: 1872–1879 10.1038/sj.onc.1206350 [doi];1206350 [pii].
[29]
Kim B, Bang S, Lee S, Kim S, Jung Y, et al. (2003) Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 63: 8248–8255.
[30]
Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, et al. (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233–240.
[31]
Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, et al. (2011) Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 17: 2693–2701 1078-0432.CCR-10-2203 [pii];10.1158/1078-0432.CCR-10–2203 [doi].
[32]
(2009) TNM classification of malignant tumours. Chichester, West Sussex, UK: A John Wiley & Sons, Ltd.
[33]
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264.
[34]
Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185–193.
[35]
Su H, Hu N, Yang HH, Wang C, Takikita M, et al. (2011) Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res 17: 2955–2966 1078-0432.CCR-10–2724 [pii];10.1158/1078-0432.CCR-10-2724 [doi].
[36]
Hu N, Qian L, Hu Y, Shou JZ, Wang C, et al. (2006) Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL, and EVPL in esophageal squamous cell carcinoma. BMC Cancer 6: 33.
[37]
Tytgat GN, Bartelink H, Bernards R, Giaccone G, van Lanschot JJ, et al. (2004) Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus 17: 10–26 10.1111/j.1442-2050.2004.00371.x [doi];DES371 [pii].
[38]
Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, et al.. (2001) Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 61: 1–9. 55345 [pii].
[39]
Chen X, Leung SY, Yuen ST, Chu KM, Ji J, et al. (2003) Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14: 3208–3215 10.1091/mbc.E02-12-0833 [doi];E02-12-0833 [pii].
[40]
Rio FT, Lavoie J, Hamel N, Geyer FC, Kushner YB, et al. (2010) Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia. N Engl J Med 363: 2628–2637 10.1056/NEJMoa1006565 [doi].
[41]
Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, et al. (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43: 34–41 ng.722 [pii];10.1038/ng.722 [doi].
[42]
Huch M, Clevers H (2011) Sox9 marks adult organ progenitors. Nat Genet 43: 9–10 ng0111-9 [pii];10.1038/ng0111-9 [doi].
[43]
Su H, Hu N, Shih J, Hu Y, Wang QH, et al. (2003) Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 63: 3872–3876.
Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, et al. (2006) Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 16: 981–988.
[46]
Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, et al. (2009) Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res 154: 13–20 S0022-4804(08)00344-2 [pii];10.1016/j.jss.2008.04.043 [doi].
[47]
van DH, Tilanus HW, Hop WC, Dinjens WN, Wink JC, et al. (2009) Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction. Cancer Genet Cytogenet 189: 37–42 S0165-4608(08)00536-0 [pii];10.1016/j.cancergencyto.2008.08.018 [doi].
[48]
Peng CW, Liu XL, Liu X, Li Y (2010) Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 8: 101 1479-5876-8-101 [pii];10.1186/1479-5876-8-101 [doi].
[49]
Fujimura T, Takahashi S, Urano T, Ijichi N, Ikeda K, et al. (2010) Differential expression of estrogen-related receptors beta and gamma (ERRbeta and ERRgamma) and their clinical significance in human prostate cancer. Cancer Sci 101: 646–651 CAS1451 [pii];10.1111/j.1349-7006.2009.01451.x [doi].
